-
Je něco špatně v tomto záznamu ?
Role of magnetic resonance in the detection of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis: Single center experience
K. Kysperska, P. Kuchynka, A. Slovakova, L. Roblova, S. Havranek, Z. Fingrova, J. Habasko, M. Masek, L. Lambert, L. Navratova, T. Palecek
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2003
Medline Complete (EBSCOhost)
od 2013-04-01
ROAD: Directory of Open Access Scholarly Resources
od 2003
PubMed
35775447
DOI
10.33963/kp.a2022.0163
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- gadolinium MeSH
- kardiomyopatie * diagnostické zobrazování MeSH
- kontrastní látky MeSH
- lidé MeSH
- magnetická rezonanční spektroskopie MeSH
- magnetická rezonanční tomografie MeSH
- nemoci srdce * MeSH
- sarkoidóza * diagnóza diagnostické zobrazování MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Sarcoidosis is a systemic inflammatory disease of unknown etiology, which can affect almost any organ. Cardiac involvement determines the prognosis of the affected individuals. Its prevalence in patients with extracardiac sarcoidosis with the absence of cardiac symptoms remains unclear. Cardiac magnetic resonance (CMR) provides excellent diagnostic accuracy in the detection of heart involvement by sarcoidosis. AIM: We sought to determine the prevalence of cardiac sarcoidosis in asymptomatic individuals with newly diagnosed extracardiac sarcoidosis using CMR. METHODS: We prospectively evaluated 55 consecutive patients including 23 women with newly diagnosed extracardiac sarcoidosis who underwent contrast-enhanced CMR and had no symptoms of heart disease. The mean (standard deviation) age of patients was 43 (11) years. The presence of myocardial late gadolinium enhancement (LGE) of non-ischemic etiology on CMR examination was considered diagnostic for cardiac sarcoidosis. RESULTS: In 3 (6%) patients, the LGE pattern consistent with cardiac sarcoidosis was detected. In all patients, preserved left ventricular systolic regional and global function was present, and in none of them, the elevation of blood biomarkers of myocardial injury or overload was found. CONCLUSIONS: Our study suggests that the prevalence of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis and no symptoms of heart disease is very low as assessed by CMR. However, CMR may be considered as part of routine evaluation of patients with extracardiac sarcoidosis due to its higher diagnostic yield in comparison with echocardiography and electrocardiography, respectively.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22033382
- 003
- CZ-PrNML
- 005
- 20230131151624.0
- 007
- ta
- 008
- 230120s2022 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33963/KP.a2022.0163 $2 doi
- 035 __
- $a (PubMed)35775447
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Kysperska, Kristyna $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 245 10
- $a Role of magnetic resonance in the detection of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis: Single center experience / $c K. Kysperska, P. Kuchynka, A. Slovakova, L. Roblova, S. Havranek, Z. Fingrova, J. Habasko, M. Masek, L. Lambert, L. Navratova, T. Palecek
- 520 9_
- $a BACKGROUND: Sarcoidosis is a systemic inflammatory disease of unknown etiology, which can affect almost any organ. Cardiac involvement determines the prognosis of the affected individuals. Its prevalence in patients with extracardiac sarcoidosis with the absence of cardiac symptoms remains unclear. Cardiac magnetic resonance (CMR) provides excellent diagnostic accuracy in the detection of heart involvement by sarcoidosis. AIM: We sought to determine the prevalence of cardiac sarcoidosis in asymptomatic individuals with newly diagnosed extracardiac sarcoidosis using CMR. METHODS: We prospectively evaluated 55 consecutive patients including 23 women with newly diagnosed extracardiac sarcoidosis who underwent contrast-enhanced CMR and had no symptoms of heart disease. The mean (standard deviation) age of patients was 43 (11) years. The presence of myocardial late gadolinium enhancement (LGE) of non-ischemic etiology on CMR examination was considered diagnostic for cardiac sarcoidosis. RESULTS: In 3 (6%) patients, the LGE pattern consistent with cardiac sarcoidosis was detected. In all patients, preserved left ventricular systolic regional and global function was present, and in none of them, the elevation of blood biomarkers of myocardial injury or overload was found. CONCLUSIONS: Our study suggests that the prevalence of cardiac involvement in patients with newly diagnosed extracardiac sarcoidosis and no symptoms of heart disease is very low as assessed by CMR. However, CMR may be considered as part of routine evaluation of patients with extracardiac sarcoidosis due to its higher diagnostic yield in comparison with echocardiography and electrocardiography, respectively.
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a kardiomyopatie $x diagnostické zobrazování $7 D009202
- 650 _2
- $a kontrastní látky $7 D003287
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a gadolinium $7 D005682
- 650 12
- $a nemoci srdce $7 D006331
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 12
- $a sarkoidóza $x diagnóza $x diagnostické zobrazování $7 D012507
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kuchynka, Petr $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. petr.kuchynka@vfn.cz
- 700 1_
- $a Slovakova, Alena $u 1st Department of Tuberculosis and Respiratory Diseases, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Roblova, Lenka $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Havranek, Stepan $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Fingrova, Zdenka $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Habasko, Jan $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Masek, Martin $u Department of Radiology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Lambert, Lukas $u Department of Radiology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Navratova, Lenka $u 1st Department of Tuberculosis and Respiratory Diseases, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Palecek, Tomas $u 2nd Department of Medicine, Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
- 773 0_
- $w MED00003056 $t Kardiologia polska $x 1897-4279 $g Roč. 80, č. 9 (2022), s. 897-901
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35775447 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151620 $b ABA008
- 999 __
- $a ok $b bmc $g 1891909 $s 1184717
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 80 $c 9 $d 897-901 $e 20220701 $i 1897-4279 $m Kardiologia Polska $n Kardiol Pol $x MED00003056
- LZP __
- $a Pubmed-20230120